Cargando…

538. Clinical Evaluation of Drug-drug Interactions with Remdesivir

BACKGROUND: Remdesivir (RDV), a nucleotide prodrug approved for COVID-19, is a substrate and inhibitor of organic anion-transporter polyprotein (OATP) transporters and cytochrome P450 3A4 (CYP3A4) metabolizing enzyme based on in vitro data. Here, clinical studies of potential drug-drug interactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Chi-Chi, Shelton, Mark, Raut, Anuja, Kwan, Anna, Chhabra, Kanika, Shen, Gong, Xiao, Deqing, Kim, Aryun, Madera, Sharline, Hyland, Robert H, Winter, Helen, Humeniuk, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678247/ http://dx.doi.org/10.1093/ofid/ofad500.607

Ejemplares similares

505. Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19
por: Amini, Elham, et al.
Publicado: (2023)

Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
por: Humeniuk, Rita, et al.
Publicado: (2023)

538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis
por: Demot, Bernard, et al.
Publicado: (2021)

538. Integrase Inhibitor-Based HAART Is Associated with Greater BMI Gains in Blacks, Hispanics, and Women
por: Bedimo, Roger, et al.
Publicado: (2018)

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects
por: Humeniuk, Rita, et al.
Publicado: (2020)

538. Extended-Spectrum β-Lactamase (ESBL): Producing Enterobacteriaceae Surveillance Pilot, New Mexico, 2017
por: Phipps, Erin C, et al.
Publicado: (2019)

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
por: Humeniuk, Rita, et al.
Publicado: (2021)

Reply to Yan and Muller, “Remdesivir for COVID-19: Why Not Dose Higher?”
por: Juneja, Kavita, et al.
Publicado: (2021)

538. Percent Positivity of COVID-19 Testing in Children of Racial/Ethnic Minority Groups in Mississippi
por: Inagaki, Kengo, et al.
Publicado: (2020)

524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies
por: Force, Lindsey, et al.
Publicado: (2023)

Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies
por: Xiao, Deqing, et al.
Publicado: (2021)

Safety profile of the antiviral drug remdesivir: An update
por: Fan, Qianqian, et al.
Publicado: (2020)

MON-538 Ca(2+)Allostery in PTH-Receptor Signaling
por: White, Alex, et al.
Publicado: (2019)

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
por: Criner, Gerard J, et al.
Publicado: (2020)

506. Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19
por: Andreatta, Kristen, et al.
Publicado: (2023)

72. Remdesivir vs Standard Care in Patients with Moderate covid-19
por: Marty, Francisco M, et al.
Publicado: (2020)

Draft Genome Sequence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Strain from a Returned Traveler from Pakistan
por: Hao, Samantha, et al.
Publicado: (2020)

Reply to Yan and Muller, “Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver”
por: Murakami, Eisuke, et al.
Publicado: (2021)

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
por: Petrakis, Vasilis, et al.
Publicado: (2022)

538. Human neutrophil gelatinase-associated protein (N-gal) and proinflammatory cytokines as biomarkers of disease severity in children with Hemolyitic Uremic Syndrom (HUS) and Shigatoxin-producing E.coli (STEC) infection.
por: Toledano, Analía, et al.
Publicado: (2022)

The Future Programme of CERN - Admininstrative Arrangements (CERN/538) (Emglish version only)
Publicado: (1964)

Predictive Factors of Recurrence of Papillary Thyroid Microcarcinomas: Analysis of 2,538 Patients
por: Carvalho, Andre de Ywata, et al.
Publicado: (2021)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Indian perspective of remdesivir: A promising COVID-19 drug
por: Singh, Devendra, et al.
Publicado: (2020)

Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
por: Nies, Anne T., et al.
Publicado: (2021)

ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
por: Deb, Subrata, et al.
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report
Publicado: (2022)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting
por: Vo, Vinny P, et al.
Publicado: (2023)

557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients
por: Arribas, Jose Ramon, et al.
Publicado: (2020)

Learning curve of uniportal video-assisted thoracoscopic lobectomy: an analysis of the proficiency of 538 cases from a single centre
por: Li, Wen-Hao, et al.
Publicado: (2022)

1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans
por: Jeyapalina, Sujee, et al.
Publicado: (2022)

541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
por: Platzer, Moritz, et al.
Publicado: (2023)

544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital
por: Rodriguez, Brittany, et al.
Publicado: (2023)

538 Long-term Follow Up Outcomes of Early Intervention with Anti-Inflammatory Therapy in Patients with Asthma Under 2 Year-old
por: Ikeda, Masanori, et al.
Publicado: (2012)

Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients
por: Sharen, Gaowa, et al.
Publicado: (2017)

538 Partial Thickness Pediatric Burn Injuries Treated with Autologous Skin Cell Suspension
por: Kopari, Nicole M, et al.
Publicado: (2022)

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective
por: Gandhi, Zainab, et al.
Publicado: (2020)

SAT-538 A Dedicated Inpatient Bone Health Team Improves Screening Rates for Osteoporosis
por: Grotzke, Marissa, et al.
Publicado: (2019)

Nonneoplastic Cystic Lesions of the Central Nervous System—Histomorphological Spectrum: A Study of 538 Cases
por: Bhatt, Anusha S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ihvlniuhpjqpm9nrsrr14ngsu8